3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Anemia, Iron-Deficiency
2
Anemia
1
Anaemia in Ovarian Carcinoma
1
Interventions
Epoetin Alfa
10
Darbepoetin alfa
8
ferric carboxymaltose
7
fludarabine
4
Cyclophosphamide
4
Busulfan
4
Blood Transfusion
4
fludarabine phosphate
3
Filgrastim
3
Erythrocyte Transfusion
3
Cyclosporine
3
Biopsy
3
Antilymphocyte Serum
3
thymoglobulin
2
ruxolitinib
2
iron isomaltoside 1000
2
ferrous sulfate
2
ferrous fumarate
2
ferric gluconate
2
Vitamin B 12
2
Thiotepa
2
Therapeutics
2
Taxes
2
Surveys and Questionnaires
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Lenalidomide
2
Folic Acid
2
Ferric Oxide, Saccharated
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Anemia
×
ferric derisomaltose
×
Clear all
NCT05407987
2025-04-25
FORGE II
AHS Cancer Control Alberta
Phase 3
Recruiting
82 enrolled